Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Nifedipine hydrochloride

Base Information Edit
  • Chemical Name:Nifedipine hydrochloride
  • CAS No.:60299-11-8
  • Molecular Formula:C17H18 N2 O6 . Cl H
  • Molecular Weight:346.3346
  • Hs Code.:
  • European Community (EC) Number:262-148-4
  • UNII:9626V3KSPM
  • DSSTox Substance ID:DTXSID90209045
  • Wikidata:Q27271845
  • Mol file:60299-11-8.mol
Nifedipine hydrochloride

Synonyms:Nifedipine hydrochloride;60299-11-8;Nifedipine HCl;Coracten XL;UNII-9626V3KSPM;9626V3KSPM;EINECS 262-148-4;Dimethyl 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)pyridine-3,5-dicarboxylate monohydrochloride;dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;hydrochloride;C17H18N2O6.ClH;SCHEMBL3858071;DTXSID90209045;C17-H18-N2-O6.Cl-H;Q27271845;3,5-PYRIDINEDICARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-4-(2-NITROPHENYL)-, 3,5-DIMETHYL ESTER, HYDROCHLORIDE (1:1);3,5-Pyridinedicarboxylicacid,1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-,3,5-dimethyl ester,hydrochloride(1:1)

Suppliers and Price of Nifedipine hydrochloride
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
Total 13 raw suppliers
Chemical Property of Nifedipine hydrochloride Edit
Chemical Property:
  • Vapor Pressure:3.37E-09mmHg at 25°C 
  • Melting Point:172-174oC 
  • Boiling Point:475.3 °C at 760 mmHg 
  • Flash Point:241.2 °C 
  • PSA:110.45000 
  • Density:1.271 g/cm3 
  • LogP:3.82960 
  • Hydrogen Bond Donor Count:2
  • Hydrogen Bond Acceptor Count:7
  • Rotatable Bond Count:5
  • Exact Mass:382.0931640
  • Heavy Atom Count:26
  • Complexity:608
Purity/Quality:

99% *data from raw suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:

SDS file from LookChem

Useful:
  • Canonical SMILES:CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC.Cl
  • Recent EU Clinical Trials:Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: a multicentre placebo controlled randomised trial of a calcium channel blocker(nifedipine)and an alpha blocker(tamsulosin) - The SUSPEND trial
Post RFQ for Price